Association of shock index with short-term and long-term prognosis after ST-segment elevation myocardial infarction

Gjin Ndrepepa1, Salvatore Cassese1, Erion Xhepa1

  • 1Department of Adult Cardiology, Deutsches Herzzentrum München.

Coronary Artery Disease
|October 3, 2019
PubMed

Insights

Elevated shock index in ST-segment elevation myocardial infarction (STEMI) patients is linked to higher in-hospital cardiogenic shock and eight-year mortality. However, long-term adverse outcomes are primarily driven by early deaths within 30 days post-procedure.

Area of Science:

  • Cardiology
  • Clinical Medicine
  • Mortalitry Research

Background:

  • The prognostic value of the shock index for long-term mortality following ST-segment elevation myocardial infarction (STEMI) is not well-established.
  • This study investigates the association between the shock index and eight-year mortality in STEMI patients.

Purpose of the Study:

  • To determine the relationship between the shock index and long-term mortality after primary percutaneous coronary intervention (PPCI) in STEMI patients.
  • To assess the risk of in-hospital cardiogenic shock and mortality up to eight years post-PPCI based on shock index tertiles.

Main Methods:

  • A cohort of 1369 STEMI patients undergoing PPCI was analyzed.
  • Patients were stratified into three groups based on shock index tertiles (0.21-0.52, >0.52-0.67, >0.67-2.80).
  • The primary endpoint was eight-year mortality, with secondary analyses including in-hospital cardiogenic shock and 30-day mortality.

Main Results:

  • Higher shock index tertiles were significantly associated with increased rates of in-hospital cardiogenic shock (26.2% in the highest tertile) and 30-day mortality (18.5% in the highest tertile).
  • Eight-year mortality also showed a significant association with the shock index (36.1% in the highest tertile).
  • Risk estimates for mortality increased per 0.1 unit increment in shock index, but long-term mortality from 30 days to 8 years did not differ significantly between tertiles.

Conclusions:

  • An elevated shock index in STEMI patients undergoing PPCI is a significant predictor of in-hospital cardiogenic shock and mortality up to eight years.
  • The observed long-term adverse prognosis is predominantly influenced by mortality events occurring within the first 30 days after PPCI.
Abstract

Related Concept Videos

Acute Coronary Syndrome III: Diagnostic Studies01:30

Acute Coronary Syndrome III: Diagnostic Studies

Diagnosing acute coronary syndrome or ACS begins with a thorough patient history. Notable symptoms include central, crushing chest pain radiating to the left arm, neck, jaw, or back, along with shortness of breath, sweating (diaphoresis), nausea, vomiting, dizziness, and palpitations.It is crucial to note any history of cardiac illnesses and assess risk factors, including age, gender, smoking, hypertension, diabetes, hyperlipidemia, and a sedentary lifestyle.During physical examination, vital...
190
Acute Coronary Syndrome I: Introduction01:30

Acute Coronary Syndrome I: Introduction

Acute Coronary Syndrome (ACS) encompasses a spectrum of heart conditions caused by sudden obstruction of coronary arteries, typically resulting from the rupture of an atherosclerotic plaque and subsequent thrombus (blood clot) formation. This obstruction can lead to partial or complete blockage of blood flow, causing varying degrees of myocardial ischemia or infarction.ACS includes the following clinical entities:Unstable Angina (UA)Non-ST-Elevation Myocardial Infarction (NSTEMI)ST-Elevation...
690
Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations01:19

Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations

The pathophysiology of Acute Coronary Syndrome [ACD] involves several key processes:The main underlying cause of ACD is atherosclerosis, a chronic inflammatory disease characterized by the buildup of lipid-laden plaques within the coronary arteries.As the atherosclerotic plaque grows in the coronary artery, it may become unstable due to the formation of a lipid-rich core and a thin fibrous cap. Inflammatory cells within the plaque, such as macrophages, secrete enzymes that degrade the...
323
Acute Coronary Syndrome IV: Interprofessional Care01:28

Acute Coronary Syndrome IV: Interprofessional Care

IntroductionThe management of Acute Coronary Syndrome (ACS) aims to minimize myocardial damage, preserve myocardial function, and prevent complications.Initial ManagementInpatient management involves continuous cardiac monitoring, preferably in an ICU, focusing on blood pressure, serum sodium, potassium, and creatinine levels, and urine output. Ongoing pharmacologic management is crucial for stabilizing the patient.Supplemental Oxygen: Administer supplemental oxygen if oxygen saturation is...
194
Blood Studies for Cardiovascular System I: Cardiac Biomarkers01:20

Blood Studies for Cardiovascular System I: Cardiac Biomarkers

Cardiac biomarkers are enzymes, proteins, and hormones released into the blood when cardiac cells are injured. They are powerful tools for triaging.
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...
746